Loading...

Centogene N.V.

CNTGNASDAQ
Healthcare
Medical - Diagnostics & Research
$0.33
$0.00(0.00%)

Centogene N.V. CNTG Peers

See (CNTG) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CNTG$0.33+0.00%9.4M-0.23-$1.39N/A
DHR-PB$1,261.26-0.78%916.8B146.01$8.64+0.58%
TMO$427.76+1.49%161.5B25.07$17.06+0.38%
DHR$202.50+0.70%144.9B39.15$5.17+0.58%
IDXX$542.71+0.01%43.6B50.19$10.81N/A
A$120.66+0.17%34.3B29.71$4.06+0.81%
IQV$164.65+1.25%28.5B22.47$7.33N/A
MTD$1,205.65+0.03%25.1B30.15$40.04N/A
NTRA$161.57+0.53%22.1B-109.16-$1.48N/A
WAT$351.92-1.43%20.9B31.89$11.03N/A
Showing 1 to 10 of 89 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CNTG vs DHR-PB Comparison

CNTG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CNTG stands at 9.4M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, CNTG is priced at $0.33, while DHR-PB trades at $1,261.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CNTG currently has a P/E ratio of -0.23, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, CNTG's ROE is +3.98%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, CNTG is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for CNTG.

Stock Price Comparison

Loading...

Frequently Asked Questions

;